毕赤酵母表达手册

合集下载

毕赤酵母表达操作手册(PDF精译版)

所有资源请在下载后 24 小时内删除。

如果您觉得满意，请购买正版，以便更好支持您所喜欢的软件或书籍！☆☆☆☆☆生物秀[]☆☆☆☆☆中国生物科学论坛[/bbs/]☆☆☆☆☆生物秀下载频道[/Soft/]生物秀——倾力打造最大最专业的生物资源下载平台！■■■ 选择生物秀，我秀我精彩！！■■■欢迎到生物秀论坛（中国生物科学论坛）的相关资源、软件版块参与讨论，共享您的资源，获取更多资源或帮助。

毕赤酵母多拷贝表达载体试剂盒用于在含多拷贝基因的毕赤酵母菌中表达并分离重组蛋白综述：基本特征：作为真核生物，毕赤酵母具有高等真核表达系统的许多优点：如蛋白加工、折叠、翻译后修饰等。

不仅如此，操作时与E.coli及酿酒酵母同样简单。

它比杆状病毒或哺乳动物组织培养等其它真核表达系统更快捷、简单、廉价，且表达水平更高。

同为酵母，毕赤酵母具有与酿酒酵母相似的分子及遗传操作优点，且它的外源蛋白表达水平是后者的十倍以至百倍。

这些使得毕赤酵母成为非常有用的蛋白表达系统。

与酿酒酵母相似技术：许多技术可以通用：互补转化基因置换基因破坏另外，在酿酒酵母中应用的术语也可用于毕赤酵母。

例如：HIS4基因都编码组氨酸脱氢酶；两者中基因产物有交叉互补；酿酒酵母中的一些野生型基因与毕赤酵母中的突变基因相互补，如HIS4、LEU2、ARG4、TR11、URA3等基因在毕赤酵母中都有各自相互补的突变基因。

毕赤酵母是甲醇营养型酵母：毕赤酵母是甲醇营养型酵母，可利用甲醇作为其唯一碳源。

甲醇代谢的第一步是：醇氧化酶利用氧分子将甲醇氧化为甲醛，还有过氧化氢。

为避免过氧化氢的毒性，甲醛代谢主要在一个特殊的细胞器－过氧化物酶体－里进行，使得有毒的副产物远离细胞其余组分。

毕赤酵母发酵手册

毕赤酵母发酵手册总览简介：毕赤酵母和酿酒酵母很相似，都非常适合发酵生长。

毕赤酵母在有可能提高总体的蛋白质产量的发酵中能够达到非常高的细胞浓度，我们建议只有那些有过发酵经验或者能得到有经验的人的指导的人参与发酵。

因为发酵的类型很多，所以我们很难为您的个人案例提高详细的过程。

下面所给出的指导是基于Mut+和Mut s两种基因型的毕赤酵母菌株在15L的台式玻璃发酵罐中发酵而成。

请在您的发酵开始前先阅读操作员手册。

下面所给出的表就发酵参数：在整个发酵过程中监测和调控下列参数非常重要。

下面的表格描述了这些参设备推荐：下面是所推荐设备的清单：·发酵罐的夹套需要在发酵过程中给酵母菌降温，尤其是在甲醇流加过程中。

你需要一个固定的来源来提供冷却水（5-10℃）。

这可能意味着你需要一个冷冻装置来保持水的冷却。

·一个泡沫探针就像消泡剂一样不可或缺。

·一个氧气的来源——空气（不锈钢的发酵罐需要1-2vvm）或者纯氧（玻璃发酵罐需要0.1-0.3vvm）。

·添加甘油和甲醇的补料泵。

·pH的自动控制。

培养基的准备：你需要准确配置下列溶液：·发酵所需的基本盐类（第11页）·PTM1补充盐类（第11页）·75ml的50％的甘油每升初始发酵液，12ml的PTM1补充盐每升甘油。

·740ml的100％的甲醇每升初始发酵液，12ml的PTM1补充盐每升甲醇。

毕赤酵母生长的测定：在不同的时间点通过测OD600的吸光值和湿细胞的重量来检测毕赤酵母的生长。

培养的代谢速率通过通过观察溶氧浓度对应于有效碳源来测定。

溶氧的测定：简介：溶解氧的浓度时指氧气在培养基中的相关比例，溶氧100％是指培养基中氧达到饱和。

毕赤酵母的生长需要消耗氧气，减少溶解氧的满度。

毕赤酵母在生长时会消耗氧气，减少溶氧的程度。

然而，因为代谢甲醇的最初阶段需要氧气，所以将溶氧浓度维持在一个适当的水平（＞20％）来确保毕赤酵母在甲醇上的生长就至关重要。

毕赤酵母手册

毕赤酵母表达实验手册作者：Jnuxz 来源：丁香园时间：2007-9-5大肠杆菌表达系统最突出的优点是工艺简单、产量高、周期短、生产成本低。

然而，许多蛋白质在翻译后，需经过翻译后的修饰加工，如磷酸化、糖基化、酰胺化及蛋白酶水解等过程才能转化成活性形式。

大肠杆菌缺少上述加工机制，不适合用于表达结构复杂的蛋白质。

另外，蛋白质的活性还依赖于形成正确的二硫键并折叠成高级结构，在大肠杆菌中表达的蛋白质往往不能进行正确的折叠，是以包含体状态存在。

包含体的形成虽然简化了产物的纯化，但不利于产物的活性，为了得到有活性的蛋白，就需要进行变性溶解及复性等操作，这一过程比较繁琐，同时增加了成本。

大肠杆菌是用得最多、研究最成熟的基因工程表达系统，当前已商业化的基因工程产品大多是通过大肠杆菌表达的，其主要优点是成本低、产量高、易于操作。

但大肠杆菌是原核生物，不具有真核生物的基因表达调控机制和蛋白质的加工修饰能力，其产物往住形成没有活性的包涵体，需要经过变性、复性等处理，才能应用。

近年来，以酵母作为工程菌表达外源蛋白日益引起重视，原因是与大肠杆菌相比，酵母是低等真核生物，除了具有细胞生长快，易于培养，遗传操作简单等原核生物的特点外，又具有真核生物时表达的蛋白质进行正确加工，修饰，合理的空间折叠等功能，非常有利于真核基因的表达，能有效克服大肠杆菌系统缺乏蛋白翻译后加工、修饰的不足。

因此酵母表达系统受到越来越多的重视和利用。

［1］。

同时与大肠杆菌相比，作为单细胞真核生物的酵母菌具有比较完备的基因表达调控机制和对表达产物的加工修饰能力。

酿酒酵母（Saccharomyces.Cerevisiae）在分子遗传学方面被人们的认识最早，也是最先作为外源基因表达的酵母宿主。

1981年酿酒酵母表达了第一个外源基因----干扰素基因［2］，随后又有一系列外源基因在该系统得到表达［3、4、5、6］。

干扰素和胰岛素虽然已经利用酿酒酵母大量生产并被广泛应用，当利用酿酒酵母制备时，实验室的结果很令人鼓舞，但由实验室扩展到工业规模时，其产量迅速下降。

酵母表达系统步骤

毕赤酵母表达系统步骤（参考Invitrogen公司说明书）：一、pPICZαA、B、C质粒以及DH5α菌株的保存1取0.5μl pPICZα A、B、C质粒，热击转化DH5α，在低盐LB（含有25μg/ml Zeocin）的平板上37℃培养过夜。

2挑取转化子，甘油保存。

二、载体构建1将目的基因构建到pPICZα载体上，转化DH5α，用Zeocin筛选转化子。

2提质粒酶切鉴定或PCR鉴定3载体测序测序可用α-Factor引物或5’AOX1引物，3’AOX1引物三、线性化DNA1提取足够量的质粒DNA（一次转化至少需要5-10μg质粒）2 酶切线性化10μg构建好的载体，同时酶切空载体做对照，根据载体选择线性化酶切位点（样品分管酶切），pPICZα载体在5’AOX1区域有三个酶切位点可选择：SacI、PmeI、BstXI3 取1-2μl酶切产物跑电泳，确定是否酶切完全；4 过柱纯化线性化质粒（用50μl EB洗脱）；四、线性化DNA的去磷酸化处理线性化质粒43μlCIAP Buffer 5μlCIAP酶2μl四、总体积为50μl的样品37℃ 1h，过柱纯化，用30μl ddH2O洗脱；五、感受态细胞的制备实验前准备：无抗性YPD平板一个、无抗生素液体YPD培养基，100μg/ml Zeocin YPD 平板和液体、50ml离心管两个、500ml预冷的无菌水、20ml 1M 山梨醇（灭菌预冷的），0.2cm预冷的电击杯；1YPD平板划线培养菌，30℃培养2-3d；250ml三角瓶中，加入5ml YPD，挑取酵母单菌落，30℃培养过夜；3吸取0.5ml菌液，加入至含有200ml新鲜YPD的1L三角瓶中，30℃，225rpm/min培养至OD值1.3-1.5；41500g，4℃离心5min收集菌体；540ml冰预冷的无菌水重悬沉淀；61500g，4℃,5min；730ml无菌水重悬；81500g，4℃,5min；910ml 1M 山梨醇重悬；101500g，4℃,5min；11加入1ml山梨醇，重悬冰上放置，直接做转化，或加入灭菌甘油每管80ul分装，冻存于-80℃(长时间保存会影响转化效率)；六、电击转化15-10μg线性化DNA（20μl<）与80ul上述感受态细胞混合，转移至预冷的0.2cm电击杯中（点击条件：电压1.5kV；电容25µF；电阻200Ω，电击时间为4～10msec）；2冰上放置5min3电击（按生产厂商提供的适合酵母用的参数）4迅速加入1ml预冷的1M 山梨醇，转移至1.5ml EP管中530℃静置培养1-2h（如果要增加存活率，获得更多的转化克隆，可在30℃静置培养1h后，加入1mlYPD培养基，30℃200rpm培养1h后取部分涂布与不同浓度抗生素的平板）6取50、100、200ul分别涂布于含有Zeocin的YPD平板，30℃培养2-10 d至有菌落出现；7如果要筛选多拷贝转化子，将转化克隆混合在一起，涂布在Zeocin 浓度为500、1000、2000μg/ml的YPD平板，培养2-3d。

GS115毕赤酵母表达菌使用说明

GS115 毕赤酵母表达菌
编号
名称
北京华越洋生物 NRR01030 GS115 毕赤酵母表达菌
基本信息：
名称：GS115 毕赤酵母表达菌
规格：300ul 甘油菌
储存温度： -‐80℃
发突变为组氨酸野生型的概率一般低于 10-‐8。GS115 毕赤酵母可以在 YPD
培养基中生长，或者在补充有组氨酸的 minimal media 中生长，但是无法
在单独的 minimal media 中生长。GS115 毕赤酵母在做质粒转化的时候，
可采用电转化的方式将质粒转入。
基因组：
His4（基因 5 是毕赤酵母菌株，是巴斯德毕赤酵母的一种，属于真核细胞。
一般的针对原核生物的抗生素例如卡那和氨苄对酵母是无效的，因此为了
操作说明：
1，本品包含一份甘油菌，使用本甘油菌时可以不用完全融解，在甘油菌表
面蘸取少量涂板或进行液体培养即可。也可以完全融解后使用，但随着冻融次数
的增加，细菌的活力会逐渐下降。
2，为保证菌种纯正，避免其它细菌污染，尽量先划平板，然后再挑单克隆
菌落进行后续操作。
毕赤酵母适宜的生长温度是 28 至 30 度，温度超过 32 度对蛋白的表
达是有害的，并可能导致细胞的死亡。GS115 毕赤酵母是是组氨酸缺陷型
（His4 基因型），如果表达载体上携带有组氨酸基因，可补偿宿主菌的组
氨酸缺陷，因此可以在不含组氨酸的培养基上筛选转化子。这些受体菌自
养。细菌在 30-‐35℃培养箱中培养 24-‐48h，真菌在 23-‐28℃培养箱中培养 24-‐72h
（必要时，可适当延长培养时间）。

毕赤酵母常用表达载体

毕赤酵母常用培养基与载体一、毕赤酵母表达常用载体：典型的巴斯德毕赤酵母表达载体载体包含醇氧化酶－1（AOX1）基因的启动子和转录终止子（5'AOX1和3'AOX1），它们被多克隆位点（MCS）分开，外源基因可以在此插入。

此载体还包含组氨醇脱氢酶基因（HIS4）选择标记及3'AOX1区。

当整合型载体转化受体时，它的5'AOX1和3'AOX1能与染色体上的同源基因重组，从而使整个载体连同外源基因插入到受体染色体上，外源基因在5'AOX1启动子控制下表达。

毕赤酵母本身不分泌内源蛋白，而外源蛋白的分泌需要具有引导分泌的信号序列。

而由89个氨基酸组成的酿酒酵母的分泌信号—α交配因子(α-factor)引导序列已经成功地引导了几种外源蛋白的分泌。

分泌表达载体主要有：pPIC9，pPIC9K，pHIL-S1，pPICZα A，pYAM75P等。

胞内表达载体主要有：pHIL-D2，pA0815，pPIC3K，pPICZ，pHWO10，pGAPZ，pGAPZa(Invitrogen)，pPIC3.5K等。

工程菌株Y11430，MG1003，GS115 （AOX1），KM71，SMD1168。

毕赤酵母宿主菌常用的有GS115和KM71两种，都具有HIS4营养缺陷标记。

其中，GS115茵株具有AOX1基因，是Mut＋，即甲醇利用正常型；而KM71菌株的AOX1位点彼ARG4基因插入，表型为Muts，即甲醇利用缓慢型，两种菌株都适用于一般的酵母转化方法。

多拷贝表达菌株的获得方式：与自主复制的质粒型表达载体不同，整合型表达载体的拷贝数可以有很大的变化。

含多拷贝外源基因的表达菌株合成蛋白的量也较多。

体内整合可通过高遗传霉素抗性，筛选可能的多拷贝插入；而体外整合可通过连接产生外源基因的串联插入。

多拷贝表达菌株的获得方式有两种：一种是利用SDS-PAGE电泳、免疫杂交或菌落点杂交方法在大量的转化子中进行自然筛选。

毕赤酵母表达(pichia pastoris expression )实验手册(3)

毕赤酵母表达（pichia pastoris expression ）实验手册（3）液体YPD培养基可常温保存；琼脂YPD平板在4℃可保存几个月。

加入Ze ocin 100ug / ml，成为YPDZ培养基，可以4℃条件下保存1～2周。

2.4 YPDS + Zeocin 培养基（Yeast Extract Peptone Dextrose Medi um）：yeast extract 1%peptone 2%dextrose (glucose) 2%sorbitol 1 M+agar 2%+ Zeocin 100 μg/ml不管是液体 YPDS培养基，还是YPDS + Zeocin 培养基，都必须存放4℃条件下，有效期1～2周。

2.5 MGYMinimal Glycerol Medium （最小甘油培养基）（34%YNB；1%甘油；4*10-5%生物素）。

将800ml灭菌水、100ml的 10* YNB母液、2ml的500*B母液和100ml的10*GY母液混匀即可，4℃保存，保存期为2个月。

2.6 MGYHMinimal Glycerol Medium + Histidine （最小甘油培养基 + 0.004%组氨酸）在1000ml的MGY培养基中加入 10ml的100*H母液混匀，4℃保存，保存期为2个月。

2.7 RDRegeneration Dextrose Medium （葡萄糖再生培养基）（含有：1mol/L的山梨醇；2%葡萄糖；1.34%YNB；4*10-5%生物素；0. 005%氨基酸）1. 将186g的山梨醇定容至700ml，高压灭菌；2. 冷却后于45℃水浴；3. 将100ml的10*D、100ml的10*YNB；2ml的500*B；10ml的100*AA等母液和88ml无菌水混匀，预热至45℃后，与步骤2 的山梨醇溶液混合。

4℃保存。

2.8 RDHRegeneration Dextrose Medium + Histidine （葡萄糖再生培养基 + 0.004%组氨酸）在RD培养基配制的第三步中，在加入10ml的100*H母液，同时无菌水的体积减少至78ml即可，其余配制方法与RD相同。

毕赤酵母表达操作手册(精译版)

不仅如此，操作时与E.coli及酿酒酵母同样简单。

它比杆状病毒或哺乳动物组织培养等其它真核表达系统更快捷、简单、廉价，且表达水平更高。

同为酵母，毕赤酵母具有与酿酒酵母相似的分子及遗传操作优点，且它的外源蛋白表达水平是后者的十倍以至百倍。

这些使得毕赤酵母成为非常有用的蛋白表达系统。

与酿酒酵母相似技术：许多技术可以通用：互补转化基因置换基因破坏另外，在酿酒酵母中应用的术语也可用于毕赤酵母。

毕赤酵母是甲醇营养型酵母：毕赤酵母是甲醇营养型酵母，可利用甲醇作为其唯一碳源。

甲醇代谢的第一步是：醇氧化酶利用氧分子将甲醇氧化为甲醛，还有过氧化氢。

为避免过氧化氢的毒性，甲醛代谢主要在一个特殊的细胞器－过氧化物酶体－里进行，使得有毒的副产物远离细胞其余组分。

由于醇氧化酶与O2的结合率较低，因而毕赤酵母代偿性地产生大量的酶。

而调控产生醇过氧化物酶的启动子也正是驱动外源基因在毕赤酵母中表达的启动子。

两种醇氧化酶蛋白：毕赤酵母中有两个基因编码醇氧化酶－AOX1及AOX2。

细胞中大多数的醇氧化酶是AOX1基因产物。

甲醇可紧密调节、诱导AOX1基因的高水平表达，较典型的是占可溶性蛋白的30%以上。

AOX1基因已被分离，含AOX1启动子的质粒可用来促进编码外源蛋白的目的基因的表达。

AOX2基因与AOX1基因有97%的同源性，但在甲醇中带AOX2基因的菌株比带AOX1基因菌株慢得多，通过这种甲醇利用缓慢表型可分离Muts菌株。

表达：AOX1基因的表达在转录水平受调控。

毕赤酵母表达系统资料整理

毕赤酵母表黑系统之阳早格格创做Mut+战Muts毕赤酵母中有二个基果编码醇氧化酶——AOX1及AOX2，细胞中大普遍的醇氧化酶是AOX1基果产品，甲醇可稀切安排、诱导AOX1基果的下火仄表黑，较典型的是占可溶性蛋黑的30%以上.AOX1基果调控分二步：压制/去压制体制加诱导体制.简朴去道，正在含葡萄糖的培植基中，纵然加进诱导物甲醇转录仍受压制.为此，用甲醇举止劣化诱导时，推荐正在苦油培植基中培植.注意纵然正在苦油中死少(去压制)时，仍缺乏以使AOX1基果达到最矮火仄的表黑，诱导物甲醇是AOX1基果可辨表黑火仄所必须的.AOX1基果已被分散，含AOX1开用子的量粒可用去促进编码中源蛋黑的手段基果的表黑.AOX2基果与AOX1基果有97%的共源性，然而正在甲醇中戴AOX2基果的菌株比戴AOX1基果菌株缓得多，通过那种甲醇利用缓缓表型可分散Muts菌株.正在YPD(酵母膏、蛋黑胨、葡萄糖)培植基中，不管是Mut+仍旧Muts其正在对付数期删殖一倍的时间约莫为2h.Mut+战Muts菌株正在不甲醇存留的情况下死少速率是一般的，存留甲醇的情况下，Mut+正在对付数期删殖一倍的时间约莫为4至6个小时，Muts正在对付数期删殖一倍的时间约莫为18个小时.菌株GS115、X-33、KM71战SMD1168的辨别GS115、KM71战SMD1168等是用于表黑中源蛋黑的毕赤酵母受体菌，与酿酒酵母相比，毕赤酵母不会使蛋黑过糖基化，糖基化后有好处蛋黑的溶解或者产死粗确的合叠结构.GS115、KM71、SMD1168正在组氨酸脱氢酶位面(His4)有突变，是组氨酸缺陷型，如果表黑载体上携戴有组氨酸基果，可补偿宿主菌的组氨酸缺陷，果此不妨正在不含组氨酸的培植基上筛选变化子.那些受体菌自收突形成组氨酸家死型的概率普遍矮于10-8.GS115表型为Mut+，沉组表黑载体变化GS115后，少出的变化子大概是Mut+，也大概是Muts(载体与代AXO1基果)，不妨正在MM战MD 培植基上审定表型.SMD1168战GS115类似，然而SMD1168基果组中的Pep4基果爆收突变，是蛋黑酶缺陷型，可落矮蛋黑酶对付中源蛋黑的落解效率.其中X-33由于是家死型，果此耐受性比较佳，如果担心变化率的话不妨思量那种酵母菌，而X33与GS115一般皆是属于MUT＋表示型，也便是道不妨正在含甲醇的培植基中赶快死少，然而是传闻会对付中源基果表黑灵验率，KM71的亲原菌正在粗氨酸琥珀酸裂解酶基果(arg4)有突变，正在不含粗氨酸的培植基中不克不迭死少.用家死型ARG4基果(约2kb)拔出到克隆的家死型AOX1基果的BamHI(AOX1基果15/16暗号子)及SalI(AOX1基果227/228暗号子)位面，与代了AOX1基果16-227暗号子，此结构变化至KM71亲原菌(arg4his4)中，分散爆收KM71 MutsArg+His-菌株，Arg+变化子遗传领会隐现家死型AOX1被aox1::ARG4结构所与代，所以KM71所有变化子皆是Muts表型.AOX1位面不被真足缺得，表面上可用您的手段结构通过基果与代要领替换aox1::ARG4结构，那样沉组菌株的表型是His+MutsArg-，那表示着沉组菌株死万古需粗氨酸.然而仅增加粗氨酸本去不克不迭真足缓战arg4突变的效率，arg4菌株正在含粗氨酸的最小培植基中不克不迭很佳天死少.果此不推荐正在KM71中通过与代aox1::ARG4结构去赢得His＋变化子.普遍去道，如果是胞内表黑，应尽管用Muts细胞，那样得到的蛋黑产品中醇氧化酶蛋黑量较少而手段蛋黑量相对付较多，使下游杂化更易举止.而对付于分泌蛋黑的表黑，无论是甲醇利用缓(Muts)仍旧甲醇利用快(Mut+)的细胞皆可应用.基果沉组Pichia.pastoris酵母菌体内无天然量粒，所以表黑载体需与宿主染色体爆收共源沉组，将中源基果表黑框架调整于染色体中以真止中源基果的表黑，包罗开用子、中源基果克隆位面、末止序列、筛选标记表记标帜等.细菌内共源沉组被认为是沉组量粒构修历程的易面，果为已线性化的环状量粒之间爆收共源沉组的几率非常矮，所以沉组变化载体必须用特定的节制性内切酶举止线性化处理.那种处理的手段是预防随机拔出沉组时量粒正在功能区断开，制成手段基果表黑得活，让共源沉组以指定的办法爆收.表黑载体主要分为以下几类：(1)胞内表黑载体主要有pHIL-D2、pA0815、pPIC3K、pPICZ、pHWO10，pGAPZ、pGAPZa(Invitrogen)等.该类载体不妨将手段基果表黑正在胞内，不妨预防毕赤酵母的糖基化，主要符合于那些不克不迭被糖基化相闭基果的表黑；(2)分泌型表黑载体主要有pPIC9、pHIL-S1、pPICZα、pYAM75P等.由于毕赤酵母自己的泌内源蛋黑非常少，将中源蛋黑分泌到胞中，非常有好处手段蛋黑量的杂化及聚集.时常使用的分泌的旗号序列主假如由89个氨基酸组成的α接配果子(α-factor)的带领；(3)多拷贝拔出表黑载体如pPIC9K，pPIC3.5K.正在某些情况下，毕赤酵母中沉组基果多拷贝调整可减少所需蛋黑的表黑量.该载体均可用于正在体内(pPIC3.5K, pPIC9K)或者体中(pAO815)爆收并分散多拷贝拔出，共时可检测减少沉组基果的拷贝数是可减少蛋黑表黑量.体内调整可通过下遗传霉素抗性筛选大概的多拷贝拔出，而体中调整可通过对接爆收中源基果的串联拔出.正在GS115中筛选His+Mut+变化子：用SalI或者StuI线性化量粒变化GS115后，大多正在His4位面上爆收沉组，大普遍变化子是Mut+表型；然而由于量粒含有AOX1基果序列，有大概正在AOX1位面爆收沉组，损害家死型AOX1基果，爆收His+Muts变化子，则需要正在MD及MM仄板上检测可证据His+ Mut+变化子.毕赤酵母表黑时常使用培植基10×YNB(13.4%的无氨基酸酵母氮源)，134gYNB固体溶于1L蒸馏火，过滤灭菌，4℃保存.YPD真足培植基：酵母提与物10 g/L，蛋黑胨20 g/L，葡萄糖20 g/L(固体培植基含1.5%琼脂).变化培植基RDB：每100mL加进山梨醇18g(186 g/L)，琼脂糖2g(20g/L)121℃灭菌20分钟，而后待温度落至60℃以去正在超洁台上加进10×YNB 10mL(13.4 g/L)，10×葡萄糖10mL(20 g/L)，500×死物素0.2mL(4×10-4g/L)，100×AA 1mL.混匀，倒仄板(灭菌时只加进80ml火即可).采用培植基MD(最小葡萄糖)：配100mL，背80mL火中加进琼脂糖2g(20 g/L)121℃灭菌20分钟，待温度落至60℃以去正在超洁台上加进10×YNB10mL(13.4 g/L)，10×葡萄糖10mL(20 g/L)，500×死物素0.2mL(4×10-4g/L).采用培植基MM(最小甲醇)：配100mL，背90mL火中加进琼脂糖2g(20 g/L) 121℃灭菌20分钟，待温度落至60℃以去正在超洁台上加进10×YNB 10mL(13.4 g/L)，500×死物素0.2mL(4×10-4g/L)，0.5mL甲醇(0.5%).诱导表黑培植基BMGY：配1L，酵母提与物10 g/L，蛋黑胨20 g/L，3g/L K2HPO4，11.8g/L KH2PO4，加火至890mL，121℃灭菌20分钟，而后待温度落至60℃以去正在超洁台上加进10×YNB 100mL(13.4 g/L)，500×死物素1mL(4×10-4g/L)，苦油10mL.诱导表黑培植基BMMY：酵母提与物10g/L，蛋黑胨20 g/L，3g/LK2HPO4，11.8g/L KH2PO4，加火至895mL，121℃灭菌20分钟，而后待温度落至60℃以去正在超洁台上加进100×YNB 100mL(13.4 g/L)，500×死物素1mL(4×10-4g/L)，甲醇5mL.BMGY/BMMY含酵母浸出物及蛋黑胨，可宁静分泌蛋黑，遏止或者缩小分泌蛋黑的领会.如果手段蛋黑对付中性PH蛋黑酶敏感的话，可正在无缓冲培植基(MGY、MM)中表黑.如果不凭证道明您的分泌蛋黑对付中性PH 值蛋黑酶敏感，修议开初表黑时用BMMY.如果表黑蛋黑落解了，测验考查正在无缓冲培植基中举止表黑.如果以上条件仍不克不迭灵验预防蛋黑落解，可将基果转进SMD1168中，该菌株表型是his4pep4，缺得了蛋黑酶，变化与表黑步调与GS115相共，也可用于大规模收酵.用考马斯明蓝G-250测蛋黑含量。

毕赤酵母表达系统（学习资料）

毕赤酵母表达系统前言：所用表达质粒有pPIC3.5K,pAO815用于胞内表达，而pPIC9K用于分泌表达，所有载体均利用AOX1启动子来诱导高水平表达。

抗性选择：最有效的筛选遗传霉素抗性及高抗性克隆的程序需要先对HIS＋转化子进行选择，再进行不同水平遗传霉素抗性筛选。

毕赤菌株表型：毕赤酵母菌GS115 及KM71 在组氨酸脱氢酶位点（His4）有突变,因而不能合成组氨酸，所有表达质粒都有HIS4 基因可与宿主进行互补，通过不含组氨酸的培养基来选择转化子。

GS115 及KM71都可在复合培养基如YPD（YEPD）及含组氨酸的最小培养基中生长。

转化之前，GS115 及KM71 都不能在最小培养基中生长，因为它们是His-。

培养温度：毕赤酵母生长温度为28-30度（液体、平板、斜面）。

在32 度以上诱导生长时，对蛋白表达有害，甚至会导致细胞死亡。

贮存：贮存细胞几周或几月，用YPD培养基或YPD 琼脂斜面1 挑取所需菌株单克隆在YPD 平板上划线生长；2 挑取单克隆转移至YPD进行穿刺培养，30 度2 天；3 细胞在4 度可放几周几月或几年，存于－80度1 挑取所需菌株单克隆在YPD 中过夜培养；2 收集细胞，在含15%甘油的YPD 中悬浮至终OD600 为50-100（大约2.5-5.0×109细胞/ml）；3 细胞先用液氮或干冰/酒精浴中冰冻再贮存于-80 度。

注意：在4 度或－80 度长期保存后，用之前建议在MM、MD 或MGY 平板上划线培养以检测His+转化子的表型是否正确及其活力。

以质粒pPIC9K，酵母Pichia pastoris GS115为例说明做法。

载体pPIC9K酶切为点线性化质粒DNA：建议使用下列方法线性化载体以获得Mut+及Muts重组子，可能其中一个会比另一个更利于表达多拷贝重组子。

如果只想得到Muts重组子，使用KM71 菌株。

单个十字交换事件可比双重十字交换更容易、更有效地获得Muts重组菌（例如：插入A OX1或his4 而不是取代AOX1）。

毕赤酵母表达手册(详细)

毕赤酵母表达（pichia pastoris expression ）实验手册2010-07-15 10:54:56| 分类：毕赤酵母| 标签：|字号大中小订阅一．毕赤酵母表达常用溶液及缓冲液的配制二．毕赤酵母表达的培养基配制三．主要试验环节的操作 3.1 酵母菌株的分离纯化 3.2 pPICZαA原核宿主菌TOP10F’的活化培养 3.3毕赤酵母表达的试验方法 3.4 毕赤酵母电转化方法 3.5 Pichia酵母表达直接PCR鉴定重组子的方法 3.6 毕赤酵母基因组提取方法 3.7 Mut+表型重组酵母的诱导表达实验关键词：酵母实验毕赤酵母表达 pichia pastoris expression 毕赤酵母酵母菌株大肠杆菌表达系统最突出的优点是工艺简单、产量高、周期短、生产成本低。

然而，许多蛋白质在翻译后，需经过翻译后的修饰加工，如磷酸化、糖基化、酰胺化及蛋白酶水解等过程才能转化成活性形式。

大肠杆菌缺少上述加工机制，不适合用于表达结构复杂的蛋白质。

另外，蛋白质的活性还依赖于形成正确的二硫键并折叠成高级结构，在大肠杆菌中表达的蛋白质往往不能进行正确的折叠，是以包含体状态存在。

毕赤酵母表达载体pPICzalpha手册

Recommended Pichia Host Strain
We recommend using the X-33 Pichia strain as the host for expression of recombinant proteins from pPICZα . Other Pichia strains are suitable. The X-33 Pichia strain is available from Invitrogen (see page vii for ordering information) and has the following genotype and phenotype: Genotype: Wild-type Phenotype: Mut+ Continued on next page
Shipping/Storage Reference Sources
The vectors are shipped on wet ice and should be stored at –20°C. The pPICZα A, B, and C vectors may be used with the Original Pichia Expression Kit (Cat. no. K1710-01) and are included in the EasySelect™ Pichia Expression Kit (Cat. no. K1740-01) available from Invitrogen. Additional general information about recombinant protein expression in Pichia pastoris is provided in the manuals for the Original Pichia Expression Kit and the EasySelect™ Pichia Expression Kit. The manuals can be downloaded from our Website () or obtained by calling Technical Support (see page 33). For more information about the Original Pichia Expression Kit or the EasySelect™ Pichia Expression Kit, refer to our Website or contact Technical Support. More detailed information and protocols dealing with Pichia pastoris may also be found in the following general reference (see page vii for ordering information): Higgins, D. R., and Cregg, J. M. (1998) Pichia Protocols. In Methods in Molecular Biology, Vol. 103. (J. M. Walker, ed. Humana Press, Totowaer Manual

毕赤酵母表达手册

Pichia Expression KitVersion M01110225-0043Pichia Expression KitA Manual of Methods for Expression of Recombinant Proteins in Pichia pastorisCatalog no. K1710-01tech_service@iiINDIVIDUAL PICHIA EXPRESSION KIT LICENSE AGREEMENTThe Pichia Expression Kit is based on the yeast Pichia pastoris. Pichia pastoris was developed into an expression system by scientists at Salk Institute Biotechnology/Industry Associates (SIBIA) for high-level expression of recombinant proteins. All patents for Pichia pastoris and licenses for its use as an expression system are owned by Research Corporation Technologies, Inc. Tucson, Arizona. Invitrogen has an exclusive license to sell the Pichia Expression Kit to scientists for research purposes only, under the terms described below. Use of Pichia pastoris by commercial corporations requires the user to obtain a commercial license as detailed below. Before using the Pichia Expression Kit, please read the following license a greement. If you do not agree to be bound by its terms, contact Invitrogen within 10 days for authorization to return the unused Pichia Expression Kit and to receive a full credit. If you do agree to the terms of this Agreement, please complete the User Registration Card and return it to Invitrogen before using the kit.INDIVIDUAL PICHIA EXPRESSION KIT LICENSE AGREEMENTInvitrogen Corporation (INVITROGEN) grants you a non-exclusive license to use the enclosed Pichia Expression Kit (EXPRESSION KIT) for academic research or for evaluation purposes only. The EXPRESSION KIT is being transferred to you in furtherance of, and reliance on, such license. You may not use the EXPRESSION KIT, or the materials contained therein, for any commercial purpose without a license for such purpose from RESEARCH CORPORATION TECHNOLOGIES, INC., Tucson, Arizona. Commercial purposes include the use in or sale of expressed proteins as a commercial product, or use to facilitate or advance research or development of a commercial product. Commercial entities may conduct their evaluation for one year at which time this license automatically terminates. Commercial entities will be contacted by Research Corporation Technologies during the evaluation period regarding the purchase of a commercial license.Access to the EXPRESSION KIT must be limited solely to those officers, employees and students of your institution who need access thereto in order to perform the above-described research or evaluation. You must inform each of such officer, employee and student of the provisions of this Agreement and require them to agree, in writing, to be bound by the provisions of this Agreement. You may not distribute the EXPRESSION KIT to others, even those within your own institution. You may transfer modified, altered or original material from the EXPRESSION KIT to a third party following notification of INVITROGEN such that the recipient can be licensed. You may not assign, sub-license, rent lease or otherwise transfer this License or any of the rights or obligation hereunder, except as expressly permitted.This License is effective until terminated. You may terminate it at any time by destroying all Pichia expression products in your control. It will also terminate automatically if you fail to comply with the terms and conditions of the Agreement. You shall, upon termination of the License, destroy all Pichia Expression Kits in your control, and so notify INVITROGEN in writing.This License Shall be governed in its interpretation and enforcement by the laws of the State of California.Product User Registration CardPlease complete and return the enclosed Product User Registration Card for each Pichia Expression Kit that you purchase. This will serve as a record of your purchase and registration and will allow Invitrogen to provide you with technical support and manual updates. It will also allow Invitrogen to update you on future developments of and improvements to the Pichia Expression Kit. The agreement outlined above becomes effective upon our receipt of your User Registration Card or 10 days following the sale of the Pichia Expression Kit to you. Use of the kit at any time results in immediate obligation to the terms and conditions stated in this Agreement.Technical ServicesInvitrogen provides Technical Services to all of our registered Pichia Expression Kit users. Please contact us if you need assistance with the Pichia Expression Kit.United States Headquarters:Japanese Headquarters European Headquarters:Invitrogen Corporation1600 Faraday AvenueCarlsbad, CA 92008 USATel: 1 760 603 7200Tel (Toll Free): 1 800 955 6288 Fax: 1 760 602 6500E-mail:tech_service@ Invitrogen Japan K.K.Nihonbashi Hama-Cho Park Bldg. 4F2-35-4, Hama-Cho, NihonbashiTel: 81 3 3663 7972Fax: 81 3 3663 8242E-mail: jpinfo@Invitrogen Ltd3 Fountain DriveInchinnan Business ParkPaisley PA4 9RF, UKTel (Free Phone Orders): 0800 269 210Tel (General Enquiries): 0800 5345 5345Fax: +44 (0) 141 814 6287E-mail: eurotech@iiiivTable of ContentsMaterials (vii)Purchaser Notification (x)Product Qualification (xii)Introduction (1)Overview (1)Experimental Outline (3)Recombination and Integration in Pichia (7)Methods (11)Pichia Strains (11)E. coli Strains (13)Selecting a Pichia Expression Vector (14)pHIL-D2 (16)pPIC3.5 (17)pHIL-S1 (18)pPIC9 (19)Signal Sequence Processing (20)Cloning into the Pichia Expression Vectors (21)Transformation into E. coli (26)Preparation of Transforming DNA (27)Growth of Pichia for Spheroplasting (30)Preparation of Spheroplasts (32)Transformation of Pichia (34)Screening for Mut+ and Mut S Transformants (36)PCR Analysis of Pichia Integrants (40)Expression of Recombinant Pichia Strains (42)Analysis by SDS-Polyacrylamide Gel Electrophoresis (45)Optimization of Pichia Protein Expression (47)Scale-up of Expression (49)Protein Purification and Glycosylation (51)Recipes (53)E. coli Media Recipes (53)Pichia Media Recipes (54)Appendix (59)Electroporation of Pichia (59)PEG 1000 Transformation Method for Pichia (60)Lithium Chloride Transformation Method (61)Total DNA Isolation from Pichia (62)Detection of Multiple Integration Events (63)Procedure for Total RNA Isolation from Pichia (64)β-Galactosidase Assay (65)Technical Service (67)References (69)vviMaterialsKit Contents Box 1: Spheroplast Module. Store at room temperature.Reagent Amount ComponentsSOS media 20 ml 1 M Sorbitol0.3X YPD10 mM CaCl2Sterile Water 2 x 125 ml Autoclaved, deionized waterSE 2 x 125 ml 1 M Sorbitol25 mM EDTA, pH 8.0SCE 2 x 125 ml 1 M Sorbitol10 mM Sodium citrate buffer, pH 5.81 mM EDTA1 M Sorbitol2 x 125 ml --CaS 2 x 60 ml 1 M Sorbitol10 mM Tris-HCl, pH 7.5;10 mM CaCl240% PEG 25 ml 40% (w/v) PEG 3350 (Reagent grade) in waterCaT 25 ml 20 mM Tris-HCl, pH 7.520 mM CaCl2Stab Vials: Pichia and E. coli stabs. Store at +4°C.Phenotype(Pichia only)GenotypeStrain Amountstab his4Mut+GS115 1stab arg4 his4 aox1::ARG4 Mut S, Arg+KM71 1GS115 Albumin 1 stab HIS4Mut SGS115 β-Gal 1 stab HIS4Mut+stab F´ {pro AB, lac I q, lac Z∆M15, Tn10 (Tet R)} mcr A,TOP10F´ 1∆(mrr-hsd RMS-mcr BC), φ80lac Z∆M15, ∆lac X74,deo R, rec A1, ara D139, ∆(ara-leu)7697, gal U,gal K, rps L (Str R), end A1, nup G λ-.Box 2: Spheroplast Module. Store at -20°C.ComponentsReagent AmountZymolyase 10 x 20 µl 3 mg/ml Zymolyase in water(100,000 units/g lytic activity)1 M DTT 10 x 1 ml 1 M dithiothreitol in watercontinued on next pageviiKit Contents,continuedVector Box. Store at -20°C.Reagent DescriptionpHIL-D210 µg, lyophilized in TE, pH 8.0Vector for intracellular expression in PichiapPIC3.510 µg, lyophilized in TE, pH 8.0Vector for intracellular expression in PichiapHIL-S110 µg, lyophilized in TE, pH 8.0 Vector for secreted expression in Pichia. Uses the PHO1 signal sequencepPIC910 µg, lyophilized in TE, pH 8.0 Vector for secreted expression in Pichia. Uses the α-factor signal sequencePrimer Box. Store at -20°C.5´ AOX1 sequencing primer2 µg (312 pmoles), lyophilized5´-GACTGGTTCCAATTGACAAGC-3´3´ AOX1 sequencing primer2 µg (314 pmoles), lyophilized5´-GCAAATGGCATTCTGACATCC-3´α-Factor sequencing primer2 µg (315 pmoles), lyophilized5´-TACTATTGCCAGCATTGCTGC-3´Media The following prepackaged media is included for your convenience. Instructions for use are provided on the package.Media Amount Yield YP Base Medium 2 pouches 2 liters of YP mediumYP Base Agar Medium 2 pouches 2 liters of YP mediumYeast Nitrogen Base 1 pouch 500 ml of 10X YNBFor transformation of Pichia by spheroplasting, the Pichia Spheroplast Module isavailable separately from Invitrogen (see below for ordering information).Product Reactions or Amount Catalog no.Pichia Spheroplast Module 10 spheroplast preparations(50 transformations)K1720-01continued on next pageviiiRequired Equip-ment and Supplies (not provided) • 30°C rotary shaking incubator• Water baths capable of 37°C, 45°C, and 100°C• Centrifuge suitable for 50 ml conical tubes (floor or table-top)• Baffled culture flasks with metal covers (50 ml, 250 ml, 500 ml, 1000 ml, and 3 L)• 50 ml sterile, conical tubes• 6 ml and 15 ml sterile snap-top tubes (Falcon 2059 or similar)• UVSpectrophotometer• Mini agarose gel apparatus and buffers• Polyacrylamide Gel Electrophoresis apparatus and buffers• Media for transformation, growth, screening, and expression (see Recipes, pages 53-58) • 5% SDS solution (10 ml per transformation)• Sterile cheesecloth or gauze• Breaking Buffer (see Recipes, page 58)• Acid-washed glass beads (available from Sigma)• Replica-plating equipment (optional)• BeadBreaker™ (optional)ixPurchaser NotificationIntroduction The Pichia Expression Kit is based on the yeast Pichia pastoris. Pichia pastoris wasdeveloped into an expression system by scientists at Salk Institute Biotechnology/ IndustryAssociates (SIBIA) and Phillips Petroleum for high-level expression of recombinantproteins. All patents for Pichia pastoris and licenses for its use as an expression system areowned by Research Corporation Technologies (RCT), Inc., Tucson, Arizona. Forinformation on commercial licenses, please see page x.The Nature of the Invitrogen License Invitrogen has an exclusive license to sell the Pichia Expression Kit to scientists for research purposes only, under the terms described below. Use of Pichia pastoris by commercial entities for any commercial purpose requires the user to obtain a commercial license as detailed below. Before using the Pichia Expression Kit, please read the following license agreement. If you do not agree to be bound by its terms, contact Invitrogen within 10 days for authorization to return the unused Pichia Expression Kit and to receive a full credit. If you do agree to the terms of this license agreement, please complete the User Registration Card and return it to Invitrogen before using the kit.Pichia pastoris Patents Pichia pastoris is covered by one or more of the following U.S. patents and corresponding foreign patents owned and licensed by Research Corporation Technologies:4,683,293 4,808,537 4,812,405 4,818,700 4,837,148 4,855,231 4,857,467 4,879,231 4,882,279 4,885,242 4,895,800 4,929,555 5,002,876 5,004,688 5,032,516 5,122,465 5,135,868 5,166,329Individual Pichia Expression Kit License Agreement Invitrogen Corporation ("Invitrogen") grants you a non-exclusive license to use the enclosed Pichia Expression Kit ("Expression Kit") for academic research or for evaluation purposes only. The Expression Kit is being transferred to you in furtherance of, and reliance on, such license. You may not use the Expression Kit, or the materials contained therein, for any commercial purpose without a license for such purpose from Research Corporation Technologies, Inc., Tucson, Arizona.Definition of Commercial Purpose Commercial purposes include:(a) any use of Expression Products in a Commercial Product(b) any use of Expression Products in the manufacture of a Commercial Product(c) any sale of Expression Products(d) any use of Expression Products or the Expression Kit to facilitate or advanceresearch or development of a Commercial Product(e) any use of Expression Products or the Expression Kit to facilitate or advance anyresearch or development program the results of which will be applied to thedevelopment of Commercial Products"Expression Products" means products expressed with the Expression Kit, or with the use of any vectors or host strains in the Expression Kit. "Commercial Product" means any product intended for sale or commercial use.Commercial entities may conduct their evaluation for one year at which time this license automatically terminates. Research Corporation Technologies will contact commercial entities during the evaluation period regarding their desire for a commercial license.continued on next pagexPurchaser Notification, continuedIndividual Responsibilities Access to the Expression Kit must be limited solely to those officers, employees and students of your institution who need access to perform the above-described research or evaluation. You must inform each such officer, employee and student of the provisions of this license agreement and require them to agree, in writing, to be bound by the provisions of this license agreement. You may not distribute neither the Expression Kit nor the vectors or host strains contained in it to others, even to those within your own institution. You may only transfer modified, altered, or original material from the Expression Kit to a third party following written notification of, and written approval from, Invitrogen so that the recipient can be licensed. You may not assign, sub-license, rent, lease or otherwise transfer this license agreement or any of the rights or obligation thereunder, except as expressly permitted by Invitrogen and RCT.Termination of License This license agreement is effective until terminated. You may terminate it at any time by destroying all Pichia expression products in your control. It will also terminate auto-matically if you fail to comply with the terms and conditions of the license agreement. You shall, upon termination of the license agreement, destroy all Pichia Expression Kits in your control, and so notify Invitrogen in writing.This License shall be governed in its interpretation and enforcement by the laws of the State of California.Contact for Commercial Licensing Bennett Cohen, Ph.D.Research Corporation Technologies 101 North Wilmot Road, Suite 600 Tucson, Arizona 85711-3335 Phone: (520) 748-4400Fax: (520)748-0025User Registration Card Please complete and return the enclosed User Registration Card for each PichiaExpression Kit that you purchase. This will serve as a record of your purchase and regis-tration and will allow Invitrogen to provide you with technical support and manualupdates. It will also allow Invitrogen to update you on future developments and improve-ments to the Pichia Expression Kit. The agreement outlined above becomes effectiveupon our receipt of your User Registration Card or 10 days following the sale of thePichia Expression Kit to you. Use of the kit at any time results in immediate obligation tothe terms and conditions stated in this license agreement.xiProduct QualificationIntroduction This section describes the criteria used to qualify the components in the PichiaExpression Kit.Vectors All expression vectors are qualified by restriction enzyme digestion. Restriction digests must demonstrate the correct banding pattern when electrophoresed on an agarose gel.Spheroplast Reagents The spheroplast reagents are qualified by spheroplast preparation of GS115 following the protocol provided in the Pichia Expression Kit manual. At least 70% of the Pichia pastoris cells must form spheroplasts in 30 minutes or less.Pichia Strains The Pichia strains are by demonstrating viability of the culture. Single colonies should arise within 48 hours after streaking on YPD medium from the stabPrimers Sequencing primers are lot tested by automated DNA sequencing experiments.Buffers andSolutionsAll buffers and solutions are extensively tested for sterility.Media All Pichia growth and expression media are qualified by growing the GS115 Pichiastrain.xiiIntroductionOverviewReview Articles The information presented here is designed to give you a concise overview of the Pichia pastoris expression system. It is by no means exhaustive. For further information, pleaseread the articles cited in the text along with recent review articles (Buckholz and Gleeson,1991; Cregg et al., 1993; Sreekrishna et al., 1988; Wegner, 1990). A general review offoreign gene expression in yeast is also available (Romanos et al., 1992).General Characteristics of Pichia pastoris As a eukaryote, Pichia pastoris has many of the advantages of higher eukaryotic expression systems such as protein processing, protein folding, and posttranslational modification, while being as easy to manipulate as E. coli or Saccharomyces cerevisiae. It is faster, easier, and less expensive to use than other eukaryotic expression systems such as baculovirus or mammalian tissue culture, and generally gives higher expression levels. As a yeast, it shares the advantages of molecular and genetic manipulations with Saccharomyces, and has the added advantage of 10- to 100-fold higher heterologous protein expression levels. These features make Pichia very useful as a protein expression system.Similarity to Saccharomyces Many of the techniques developed for Saccharomyces may be applied to Pichia including: • transformation by complementation• genedisruption• genereplacementIn addition, the genetic nomenclature used for Saccharomyces has been applied to Pichia. For example, the HIS4 gene in both Saccharomyces and Pichia encodes histidinol dehydrogenase. There is also cross-complementation between gene products in both Saccharomyces and Pichia. Several wild-type genes from Saccharomyces complement comparable mutant genes in Pichia. Genes such as HIS4, LEU2, ARG4, TRP1, and URA3 all complement their respective mutant genes in Pichia.Pichia pastoris as a Methylotrophic Yeast Pichia pastoris is a methylotrophic yeast, capable of metabolizing methanol as its sole carbon source. The first step in the metabolism of methanol is the oxidation of methanol to formaldehyde using molecular oxygen by the enzyme alcohol oxidase. This reaction generates both formaldehyde and hydrogen peroxide. To avoid hydrogen peroxide toxicity, methanol metabolism takes place within a specialized cell organelle called the peroxisome, which sequesters toxic by-products from the rest of the cell. Alcohol oxidase has a poor affinity for O2, and Pichia pastoris compensates by generating large amounts of the enzyme. The promoter regulating the production of alcohol oxidase drives heterologous protein expression in Pichia.Two Alcohol Oxidase Proteins The AOX1 and AOX2 genes code for alcohol oxidase in Pichia pastoris. The AOX1 gene product accounts for the majority of alcohol oxidase activity in the cell. Expression of the AOX1 gene is tightly regulated and induced by methanol to high levels, typically > 30% ofthe total soluble protein in cells grown with methanol as the carbon source. The AOX1 gene has been isolated and the AOX1 promoter is used to drive expression of the gene of interest (Ellis et al., 1985; Koutz et al., 1989; Tschopp et al., 1987a). While AOX2 is about 97% homologous to AOX1, growth on methanol is much slower than with AOX1. This slowgrowth allows isolation of Mut S strains (aox1) (Cregg et al., 1989; Koutz et al., 1989).continued on next page1Overview, continuedExpression Expression of the AOX1 gene is controlled at the level of transcription. In methanol-grown cells approximately 5% of the polyA+ RNA is from the AOX1 gene. The regulation of theAOX1 gene is a two step process: a repression/derepression mechanism plus an inductionmechanism (e.g. GAL1 gene in Saccharomyces (Johnston, 1987)). Briefly, growth onglucose represses transcription, even in the presence of the inducer methanol. For thisreason, growth on glycerol is recommended for optimal induction with methanol. Pleasenote that growth on glycerol (derepression) is not sufficient to generate even minute levelsof expression from the AOX1 gene. The inducer, methanol, is necessary for detectablelevels of AOX1 expression (Ellis et al., 1985; Koutz et al., 1989; Tschopp et al., 1987a).Phenotype of aox1 mutants Loss of the AOX1 gene, and thus a loss of most of the cell's alcohol oxidase activity, results in a strain that is phenotypically Mut S (Methanol utilization slow). This has in the past been referred to as Mut. The Mut S designation has been chosen to accurately describe the phenotype of these mutants. This results in a reduction in the cells' ability to metabolize methanol. The cells, therefore, exhibit poor growth on methanol medium. Mut+ (Methanol utilization plus) refers to the wild type ability of strains to metabolize methanol as the sole carbon source. These two phenotypes are used when evaluating Pichia transformants for integration of your gene (Experimental Outline, page 3).Intracellular and Secretory Protein Expression Heterologous expression in Pichia can be either intracellular or secreted. Secretion requires the presence of a signal sequence on the expressed protein to target it to the secretory pathway. While several different secretion signal sequences have been used successfully, including the native secretion signal present on some heterologous proteins, success has been variable. The secretion signal sequence from the Saccharomyces cerevisiaeα factor prepro peptide has been used most successfully (Cregg et al., 1993; Scorer et al., 1993).The major advantage of expressing heterologous proteins as secreted proteins is that Pichia pastoris secretes very low levels of native proteins. That, combined with the very low amount of protein in the minimal Pichia growth medium, means that the secreted heterologous protein comprises the vast majority of the total protein in the medium and serves as the first step in purification of the protein (Barr et al., 1992). Note: If there are recognized glycosylation sites (Asn-X-Ser/Thr) in your protein's primary sequence, glycosylation may occur at these sites.Posttranslational Modifications In comparison to Saccharomyces cerevisiae, Pichia may have an advantage in the glyco-sylation of secreted proteins because it may not hyperglycosylate. Both Saccharomyces cerevisiae and Pichia pastoris have a majority of N-linked glycosylation of the high-mannose type; however, the length of the oligosaccharide chains added posttranslationally to proteins in Pichia (average 8-14 mannose residues per side chain) is much shorter than those in S. cerevisiae (50-150 mannose residues) (Grinna and Tschopp, 1989; Tschopp et al., 1987b). Very little O-linked glycosylation has been observed in Pichia.In addition, Saccharomyces cerevisiae core oligosaccharides have terminal α1,3 glycan linkages whereas Pichia pastoris does not. It is believed that the α1,3 glycan linkages in glycosylated proteins produced from Saccharomyces cerevisiae are primarily responsible for the hyper-antigenic nature of these proteins making them particularly unsuitable for therapeutic use. Although not proven, this is predicted to be less of a problem for glycoproteins generated in Pichia pastoris, because it may resemble the glycoprotein structure of higher eukaryotes (Cregg et al., 1993).2Experimental OutlineSelection of Vector and Cloning To utilize the strong, highly inducible P AOX1 promoter for expression of your protein, four expression vectors are included in this kit. pHIL-D2 and pPIC3.5 are used for intracellular expression while pHIL-S1 and pPIC9 are used for secreted expression (see pages 14-19 for more information). Before cloning your insert, you must...• decide whether you want intracellular or secreted expression.• analyze your insert for the following restriction sites: Sac I, Stu I, Sal I, Not I, and Bgl II. These sites are recommended for linearizing your construct prior to Pichiatransformation. If your insert has all of these sites, see pages 28-29 for alternate sites.Transformation and IntegrationTwo different phenotypic classes of His+ recombinant strains can be generated: Mut+ and Mut S. Mut S refers to the "Methanol utilization slow" phenotype caused by the loss of alcohol oxidase activity encoded by the AOX1 gene. A strain with a Mut S phenotype has a mutant aox1 locus, but is wild type for AOX2. This results in a slow growth phenotype on methanol medium. Transformation of strain GS115 can yield both classes of transformants, His+ Mut+ and His+Mut S, while KM71 yields only His+ Mut S since the strain itself is Mut S. Both Mut+ and Mut S recombinants are useful to have as one phenotype may favor better expression of your protein than the other. Due to clonal variation, you should test 6-10 recombinants per phenotype. There is no way to predict beforehand which construct or isolate will better express your protein. We strongly recommend that you analyze Pichia recombinants by PCR to confirm integration of your construct (see page 40).Once you have successfully cloned your gene, you will then linearize your plasmid to stimulate recombination when the plasmid is transformed into Pichia. The table below describes the types of recombinants you will get by selective digestion of your plasmid. RestrictionEnzymeIntegration Event GS115 Phenotype KM71 PhenotypeSal I or Stu I Insertion at his4His+ Mut+ His+ Mut SSac I Insertion at 5´AOX1 regionHis+ Mut+ His+ Mut SNot I or Bgl II Replacement atAOX1 locusHis+ Mut SHis+ Mut+His+ Mut S (notrecommended, see page 11)Expression and Scale-up After confirming your Pichia recombinants by PCR, you will test expression of both His+Mut+ and His+ Mut S recombinants. This will involve growing a small culture of each recombinant, inducing with methanol, and taking time points. If looking for intracellular expression, analyze the cell pellet from each time point by SDS polyacrylamide gel electrophoresis (SDS-PAGE). If looking for secreted expression, analyze both the cellpellet and supernatant from each time point. We recommend that you analyze your SDS-PAGE gels by both Coomassie staining and Western blot, if you have an antibody to your protein. We also suggest checking for protein activity by assay, if one is available. Not all proteins express to the level of grams per liter, so it is advisable to check by Western blotor activity assay, and not just by Coomassie staining of SDS-PAGE gels for production of your protein.Choose the Pichia recombinant strain that best expresses your protein and optimizeinduction based on the suggestions on pages 47-48. Once expression is optimized, scale-up your expression protocol to produce more protein.continued on next page3。

毕赤酵母表达步骤

毕赤酵母表达系统的构建1.确定转入的目的基因，并设计相应引物，进行PCR反应，获取目的基因片段。

（所需药品-高保真酶，引物，dntp，胶回收试剂盒。

）2.对目的基因及载体Ppic9k进行酶切产生粘性接头并纯化回收。

（所需药品- SalI、StuI、SacI 【用于于GS115产生His+Mut+】；BglII【用于于GS115产生His+Muts】）酶切体系酶切体系50 μL目的DNA 10 μL酶切缓冲液 5 μL限制性内切酶 1 μL超纯水34μL37 ℃酶切 1～4小时。

酶切产物进行琼脂糖凝胶电泳检测分析。

3.将酶切正确的目的片度与质粒相连（所需药品-连接试剂盒SolutionⅠ[宝生物]）载体DNA0.5µL目的片段DNA 4.5µL连接试剂盒SolutionⅠ 5 µL充分混匀，置于16 ℃连接4 h或4 ℃连接过夜。

4.转入DH5α扩繁质粒（所需药品- A mp；DH5α；CaCl2）将DNA目的片段和载体的连接产物与200µL感受态细胞混匀，冰浴30min。

45℃热击45-60s，冰浴3min后加入800μL LB 液体培养基37℃震荡培养1h。

（1 ）转化后，将转化混合物涂在含50-100ug/ul A mp 的LB平板上，选择A mp 抗性克隆（2）挑取10 个A mp 抗性转化子，接种含150ug/ul A mp 的培养基，37 度振荡培养过夜（3 ）提取质粒进行PCR及酶切检测并送交测序。

（pPIC9k 测序时，用α-factor 引物及3’AOX1 测序引物。

将引物重悬于20ul灭菌水中，制成0.1ug/ul 溶液）4 在0.85ml 过夜培养菌液中加入0.15ml 灭菌甘油，以便保存所需克隆，涡旋混匀转入标记好的储存管中。

在液氮或干冰/酒精浴中冷冻后移入-70 度保存。

5 测序证实结构正确后，可准备转化DNA5.毕赤酵母电转化：细胞准备：毕赤酵母感受态制备：（1）取1 mL GS115过夜培养物(OD6006．0～10．0)转接于100 mL YPD液体培养基中28℃-3O℃、250—300 r／min培养至酵母菌的对数生长期(OD600 1．0～1．3)（2）取此菌1 mL分装到1．5 mL EP管中，4℃、10 000 g离心1 min，弃上清液，沉淀用无菌水(4℃预冷)洗涤，同样条件下离心，弃上清液。

毕赤酵母发酵手册

Version B Pichia Fermentation Process GuidelinesOverviewIntroduction Pichia pastoris, like Saccharomyces cerevisiae, is particularly well-suited forfermentative growth. Pichia has the ability to reach very high cell densities duringfermentation which may improve overall protein yields.We recommend that only those with fermentation experience or those who have accessto people with experience attempt fermentation. Since there are a wide variety offermenters available, it is difficult to provide exact procedures for your particular case.The guidelines given below are based on fermentations of both Mut+ and Mut S Pichiastrains in a 15 liter table-top glass fermenter. Please read the operator's manual for yourparticular fermenter before beginning. The table below provides an overview of thematerial covered in these guidelines.Step Topic Page1 Fermentationparameters 12 Equipment needed and preparation of medium 23 Measurement and use of dissolved oxygen (DO) in the culture 34 Growth of the inoculum 45 Generation of biomass on glycerol in batch and fed-batch phases 4-56 Induction of expression of Mut+ and Mut S recombinants in themethanol fed-batch phase6-77 Harvesting and lysis of cells 88 References 9-109 Recipes 11Fermentation Parameters It is important to monitor and control the following parameters throughout thefermentation process. The following table describes the parameters and the reasons for monitoring them.Parameter Reason Temperature (30.0°C) Growth above 32°C is detrimental to protein expression Dissolved oxygen (>20%) Pichia needs oxygen to metabolize glycerol andmethanolpH (5.0-6.0 and 3.0) Important when secreting protein into the medium andfor optimal growthAgitation (500 to 1500 rpm) Maximizes oxygen concentration in the mediumAeration (0.1 to 1.0 vvm*for glass fermenters)Maximizes oxygen concentration in the medium whichdepends on the vesselAntifoam (the minimumneeded to eliminate foam)Excess foam may cause denaturation of your secretedprotein and it also reduces headspaceCarbon source (variablerate)Must be able to add different carbon sources at differentrates during the course of fermentationcontinued on next pageOverview, continuedRecommended Equipment Below is a checklist for equipment recommendations.• A jacketed vessel is needed for cooling the yeast during fermentation, especially during methanol induction. You will need a constant source of cold water (5-10°C). This requirement may mean that you need a refrigeration unit to keep the water cold. • A foam probe is highly recommended as antifoam is required.• A source of O2--either air (stainless steel fermenters at 1-2 vvm) or pure O2(0.1-0.3 vvm for glass fermenters).• Calibrated peristaltic pumps to feed the glycerol and methanol.• Automatic control of pH.Medium Preparation You will need to prepare the appropriate amount of following solutions:• Fermentation Basal Salts (page 11)• PTM1Trace Salts (page 11)• ~75 ml per liter initial fermentation volume of 50% glycerol containing 12 ml PTM1 Trace Salts per liter of glycerol.• ~740 ml per liter initial fermentation volume of 100% methanol containing 12 mlPTM1Trace Salts per liter of methanol.Monitoring the Growth of Pichia pastoris Cell growth is monitored at various time points by using the absorbance at 600 nm (OD600) and the wet cell weight. The metabolic rate of the culture is monitored by observing changes in the concentration of dissolved oxygen in response to carbon availability (see next page).Dissolved Oxygen (DO) MeasurementIntroduction The dissolved oxygen concentration is the relative percent of oxygen in the mediumwhere 100% is O2-saturated medium. Pichia will consume oxygen as it grows, reducing the dissolved oxygen content. However, because oxygen is required for the first step ofmethanol catabolism, it is important to maintain the dissolved oxygen (DO) concentra-tion at a certain level (>20%) to ensure growth of Pichia on methanol. Accuratemeasurement and observation of the dissolved oxygen concentration of a culture willgive you important information about the state and health of the culture. Therefore, it isimportant to accurately calibrate your equipment. Please refer to your operator's manual.Maintaining the Dissolved Oxygen Concentration (DO) 1. Maintaining the dissolved oxygen above 20% may be difficult depending on theoxygen transfer rates (OTR) of the fermenter, especially in small-scale glassvessels. In a glass vessel, oxygen is needed to keep the DO above 20%, usually~0.1-0.3 vvm (liters of O2per liter of fermentation culture per minute). Oxygen consumption varies and depends on the amount of methanol added and the protein being expressed.2. Oxygen can be used at 0.1 to 0.3 vvm to achieve adequate levels. This can beaccomplished by mixing with the air feed and can be done in any glass fermenter.For stainless steel vessels, pressure can be used to increase the OTR. Be sure toread the operator's manual for your particular fermenter.3. If a fermenter cannot supply the necessary levels of oxygen, then the methanol feedshould be scaled back accordingly. Note that decreasing the amount of methanol may reduce the level of protein expression.4. To reach maximum expression levels, the fermentation time can be increased todeliver similar levels of methanol at the lower feed rate. For many recombinantproteins, a direct correlation between amount of methanol consumed and theamount of protein produced has been observed.Use of DO Measurements During growth, the culture consumes oxygen, keeping the DO concentration low. Note that oxygen is consumed whether the culture is grown on glycerol or methanol. The DO concentration can be manipulated to evaluate the metabolic rate of the culture and whether the carbon source is limiting. The metabolic rate indicates how healthy the culture is. Determining whether the carbon source is limiting is important if you wish to fully induce the AOX1 promoter. For example, changes in the DO concentrations (DO spikes) allow you to determine whether all the glycerol is consumed from the culture before adding methanol. Secondly, it ensures that your methanol feed does not exceed the rate of consumption. Excess methanol (> 1-2% v/v) may be toxic.Manipulation of DO If carbon is limiting, shutting off the carbon source should cause the culture to decrease its metabolic rate, and the DO to rise (spike). Terminate the carbon feed and time how long it takes for the DO to rise 10%, after which the carbon feed is turned back on. If the lag time is short (< 1 minute), the carbon source is limiting.Fermenter Preparation and Glycerol Batch PhaseInoculum Seed Flask Preparation Remember not to put too much medium in the baffled flasks. Volume should be 10-30% of the total flask volume.1. Baffled flasks containing a total of 5-10% of the initial fermentation volume ofMGY or BMGY are inoculated with a colony from a MD or MGY plate or from a frozen glycerol stock.2. Flasks are grown at 30°C, 250-300 rpm, 16-24 hours until OD600= 2-6. Toaccurately measure OD600> 1.0, dilute a sample of your culture 10-fold before reading.Glycerol Batch Phase 1. Sterilize the fermenter with the Fermentation Basal Salts medium containing 4%glycerol (see page 11).2. After sterilization and cooling, set temperature to 30°C, agitation and aeration tooperating conditions (usually maximum rpm and 0.1-1.0 vvm air), and adjust the pH of the Fermentation Basal Salts medium to 5.0 with 28% ammonium hydroxide(undiluted ammonium hydroxide). Add aseptically 4.35 ml PTM1trace salts/liter of Fermentation Basal Salts medium.3. Inoculate fermenter with approximately 5-10% initial fermentation volume from theculture generated in the inoculum shake flasks. Note that the DO will be close to 100% before the culture starts to grow. As the culture grows, it will consumeoxygen, causing the DO to decrease. Be sure to keep the DO above 20% by adding oxygen as needed.4. Grow the batch culture until the glycerol is completely consumed (18 to 24 hours).This is indicated by an increase in the DO to 100%. Note that the length of timeneeded to consume all the glycerol will vary with the density of the initial inoculum.5. Sampling is performed at the end of each fermentation stage and at least twice daily.We take 10 ml samples for each time point, then take 1 ml aliquots from this 10 mlsample. Samples are analyzed for cell growth (OD600and wet cell weight), pH, microscopic purity, and protein concentrations or activity. Freeze the cell pellets and supernatants at -80°C for later analysis. Proceed to Glycerol Fed-Batch Phase,page 5.Yield A cellular yield of 90 to 150 g/liter wet cells is expected for this stage. Recombinant protein will not yet be produced due to the absence of methanol.Introduction Once all the glycerol is consumed from the batch growth phase, a glycerol feed isinitiated to increase the cell biomass under limiting conditions. When you are ready toinduce with methanol, you can use DO spikes to make sure the glycerol is limited.Glycerol Fed-Batch Phase 1. Initiate a 50% w/v glycerol feed containing 12 ml PTM1trace salts per liter of glycerol feed. Set the feed rate to 18.15 ml/hr /liter initial fermentation volume.2. Glycerol feeding is carried out for about four hours or longer (see below). A cellularyield of 180 to 220 g/liter wet cells should be achieved at the end of this stage while no appreciable recombinant protein is produced.Note The level of expressed protein depends on the cell mass generated during the glycerolfed-batch phase. The length of this feed can be varied to optimize protein yield. A rangeof 50 to 300 g/liter wet cells is recommended for study. A maximum level of 4%glycerol is recommended in the batch phase due to toxicity problems with higher levelsof glycerol.Important If dissolved oxygen falls below 20%, the glycerol or methanol feed should bestopped and nothing should be done to increase oxygen rates until the dissolvedoxygen spikes. At this point, adjustments can be made to agitation, aeration, pressure oroxygen feeding.Proteases In the literature, it has been reported that if the pH of the fermentation medium islowered to 3.0, neutral proteases are inhibited. If you think neutral proteases aredecreasing your protein yield, change the pH control set point to 3.0 during the glycerolfed-batch phase (above) or at the beginning of the methanol induction (next page) andallow the metabolic activity of the culture to slowly lower the pH to 3.0 over 4 to 5 hours(Brierley, et al., 1994; Siegel, et al., 1990).Alternatively, if your protein is sensitive to low pH, it has been reported that inclusion ofcasamino acids also decreases protease activity (Clare, et al., 1991).Introduction All of the glycerol needs to be consumed before starting the methanol feed to fullyinduce the AOX1 promoter on methanol. However, it has been reported that a "mixedfeed" of glycerol and methanol has been successful to express recombinant proteins(Brierley, et al., 1990; Sreekrishna, et al., 1989). It is important to introduce methanolslowly to adapt the culture to growth on methanol. If methanol is added too fast, it willkill the cells. Once the culture is adapted to methanol, it is very important to use DOspikes to analyze the state of the culture and to take time points over the course ofmethanol induction to optimize protein expression. Growth on methanol also generates alot of heat, so temperature control at this stage is very important.Mut+ Methanol Fed-Batch Phase 1. Terminate glycerol feed and initiate induction by starting a 100% methanol feedcontaining 12 ml PTM1trace salts per liter of methanol. Set the feed rate to 3.6 ml/hr per liter initial fermentation volume.2. During the first 2-3 hours, methanol will accumulate in the fermenter and thedissolved oxygen values will be erratic while the culture adapts to methanol.Eventually the DO reading will stabilize and remain constant.3. If the DO cannot be maintained above 20%, stop the methanol feed, wait for theDO to spike and continue on with the current methanol feed rate. Increaseagitation, aeration, pressure or oxygen feeding to maintain the DO above 20%. 4. When the culture is fully adapted to methanol utilization (2-4 hours), and is limitedon methanol, it will have a steady DO reading and a fast DO spike time (generally under 1 minute). Maintain the lower methanol feed rate under limited conditions for at least 1 hour after adaptation before doubling the feed. The feed rate is then doubled to ~7.3 ml/hr/liter initial fermentation volume.5 After 2 hours at the 7.3 ml/hr/liter feed rate, increase the methanol feed rate to~10.9 ml/hr per liter initial fermentation volume. This feed rate is maintainedthroughout the remainder of the fermentation.6. The entire methanol fed-batch phase lasts approximately 70 hours with a total ofapproximately 740 ml methanol fed per liter of initial volume. However, this may vary for different proteins.Note: The supernatant may appear greenish. This is normal.Yield The cell density can increase during the methanol fed-batch phase to a final level of 350 to 450 g/liter wet cells. Remember that because most of the fermentation is carried out ina fed-batch mode, the final fermentation volume will be approximately double the initialfermentation volume.Fermentation of Mut S Pichia Strains Since Mut S cultures metabolize methanol poorly, their oxygen consumption is very low. Therefore, you cannot use DO spikes to evaluate the culture. In standard fermentations of a Mut S strain, the methanol feed rate is adjusted to maintain an excess of methanol in the medium which does not exceed 0.3% (may be determined by gas chromatography). While analysis by gas chromatography will insure that nontoxic levels of methanol are maintained, we have used the empirical guidelines below to express protein in Mut S strains. A gas chromatograph is useful for analyzing and optimizing growth of Mut S recombinants.continued on next pageMethanol Fed-Batch Phase, continuedMut S Methanol Fed- Batch Phase The first two phases of the glycerol batch and fed-batch fermentations of the Mut S strains are conducted as described for the Mut+ strain fermentations. The methanol induction phases of the Mut+ and Mut S differ in terms of the manner and amount in which the methanol feed is added to the cultures.1. The methanol feed containing 12 ml PTM1trace salts per liter of methanol is initiated at 1 ml/hr/liter initial fermentation volume for the first two hours. It is then increased in 10% increments every 30 minutes to a rate of 3 ml/hr which ismaintained for the duration of the fermentation.2.. The vessel is then harvested after ~100 hours on methanol. This time may be variedto optimize protein expression.Harvesting and Lysis of CellsIntroduction The methods and equipment listed below are by no means complete. The amount of cells or the volume of supernatant will determine what sort of equipment you need.Harvesting Cells and Supernatant For small fermentations (1-10 liters), the culture can be collected into centrifuge bottles (500-1000 ml) and centrifuged to separate the cells from the supernatant.For large fermentations, large membrane filtration units (Millipore) or a Sharples centrifuge can be used to separate cells from the supernatant. The optimal method will depend on whether you need the cells or the supernatant as the source of your protein and what you have available.Supernatants can be loaded directly onto certain purification columns or concentrated using ultrafiltration.Cell Lysis We recommend cell disruption using glass beads as described in Current Protocols inMolecular Biology, page 13.13.4. (Ausubel, et al., 1990) or Guide to ProteinPurification (Deutscher, 1990). This method may be tedious for large amounts of cells.For larger amounts, we have found that a microfluidizer works very well. Frenchpressing the cells does not seem to work as well as the glass beads or the microfluidizer.ReferencesIntroduction Most of the references below refer to papers where fermentation of Pichia wasperformed. Note that some of these are patent papers. You can obtain copies of patentsusing any of the following methods.• Patent Depository Libraries. U. S. patents and international patents granted underthe Patent Cooperation Treaty (PCT) are available on microfilm. These can be copiedand mailed or faxed depending on length. There is a fee for this service. The referencelibrarian at your local library can tell you the location of the nearest Patent DepositoryLibrary.• Interlibrary Loan. If you are not near a Patent Depository Library, you may request acopy of the patent through interlibrary loan. There will be a fee for this service.• U. S. Patent Office. Requests may be made directly to the Patent Office, Arlington,VA. Please call 703-557-4636 for more information on cost and delivery.• Private Library Services. There are private companies who will retrieve and sendyou patents for a fee. Two are listed below:Library Connection: 804-758-3311Rapid Patent Services: 800-336-5010Citations Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A.,Struhl, K., eds (1990) Current Protocols in Molecular Biology. GreenePublishing Associates and Wiley-Interscience, New York.Brierley, R. A., Siegel, R. S., Bussineau, C. M. Craig, W. S., Holtz, G. C., Davis, G. R.,Buckholz, R. G., Thill, G. P., Wondrack, L. M., Digan, M. E., Harpold, M. M.,Lair, S. V., Ellis, S. B., and William, M. E. (1989) Mixed Feed RecombinantYeast Fermentation. International Patent (PCT) Application. Publication No.WO 90/03431.Brierley, R. A., Bussineau, C., Kosson, R., Melton, A., and Siegel, R. S. (1990)Fermentation Development of Recombinant Pichia pastoris Expressing theHeterologous Gene: Bovine Lysozyme. Ann. New York Acad. Sci.589: 350-362.Brierley, R. A., Davis, G. R. and Holtz, G. C. (1994) Production of Insulin-Like GrowthFactor-1 in Methylotrophic Yeast Cells. United States Patent5,324,639.Clare, J. J., Romanos, M. A., Rayment, F. B., Rowedder, J. E., Smith, M. A., Payne, M.M., Sreekrishna, K. and Henwood, C. A. (1991) Production of EpidermalGrowth Factor in Yeast: High-level Secretion Using Pichia pastoris StrainsContaining Multiple Gene Copies. Gene105: 205-212.Cregg, J. M., Tschopp, J. F., Stillman, C., Siegel, R., Akong, M., Craig, W. S.,Buckholz, R. G., Madden, K. R., Kellaris, P. A., Davis, G. R., Smiley, B. L.,Cruze, J., Torregrossa, R., Veliçelebi, G. and Thill, G. P. (1987) High-levelExpression and Efficient Assembly of Hepatitis B Surface Antigen in theMethylotrophic Yeast Pichia pastoris. Bio/Technology5: 479-485.Cregg, J. M., Vedvick, T. S. and Raschke, W. C. (1993) Recent Advances in theExpression of Foreign Genes in Pichia pastoris. Bio/Technology11: 905-910.Deutscher, M. P. (1990) Guide to Protein Purification. In: Methods in Enzymology (J.N. Abelson and M. I. Simon, eds.) Academic Press, San Diego, CA.continued on next pageReferences, continuedCitations, continuedDigan, M. E., Lair, S. V., Brierley, R. A., Siegel, R. S., Williams, M. E., Ellis, S. B., Kellaris, P. A., Provow, S. A., Craig, W. S., Veliçelebi, G., Harpold, M. M. andThill, G. P. (1989) Continuous Production of a Novel Lysozyme via Secretionfrom the Yeast Pichia pastoris. Bio/Technology7: 160-164.Hagenson, M. J., Holden, K. A., Parker, K. A., Wood, P. J., Cruze, J. A., Fuke, M., Hopkins, T. R. and Stroman, D. W. (1989) Expression of Streptokinase inPichia pastoris Yeast. Enzyme Microbiol. Technol.11: 650-656.Laroche, Y., Storme, V., Meutter, J. D., Messens, J. and Lauwereys, M. (1994) High-Level Secretion and Very Efficient Isotopic Labeling of Tick AnticoagulantPeptide (TAP) Expressed in the Methylotrophic Yeast, Pichia pastoris.Bio/Technology12: 1119-1124.Romanos, M. A., Clare, J. J., Beesley, K. M., Rayment, F. B., Ballantine, S. P., Makoff,A. J., Dougan, G., Fairweather, N. F. and Charles, I. G. (1991) RecombinantBordetella pertussis Pertactin p69 from the Yeast Pichia pastoris High LevelProduction and Immunological Properties. Vaccine9: 901-906.Siegel, R. S. and Brierley, R. A. (1989) Methylotrophic Yeast Pichia pastoris Produced in High-cell-density Fermentations With High Cell Yields as Vehicle forRecombinant Protein Production. Biotechnol. Bioeng.34: 403-404.Siegel, R. S., Buckholz, R. G., Thill, G. P., and Wondrack, L. M. (1990) Production of Epidermal Growth Factor in Methylotrophic Yeast Cells. International Patent(PCT) Application. Publication No. WO 90/10697.Sreekrishna, K., Nelles, L., Potenz, R., Cruse, J., Mazzaferro, P., Fish, W., Fuke, M., Holden, K., Phelps, D., Wood, P. and Parker, K. (1989) High LevelExpression, Purification, and Characterization of Recombinant Human TumorNecrosis Factor Synthesized in the Methylotrophic Yeast Pichia pastoris.Biochemistry28(9): 4117-4125.©2002 Invitrogen Corporation. All rights reservedRecipesFermentation Basal Salts Medium For 1 liter, mix together the following ingredients:Phosphoric acid, 85% (26.7 ml)Calcium sulfate 0.93 gPotassium sulfate 18.2 gMagnesium sulfate-7H2O 14.9gPotassium hydroxide 4.13 gGlycerol 40.0g Water to 1 literAdd to fermenter with water to the appropriate volume and sterilize.PTM1 Trace Salts Mix together the following ingredients:Cupric sulfate-5H2O 6.0gSodium iodide 0.08 gManganese sulfate-H2O 3.0gSodium molybdate-2H2O 0.2gBoric Acid 0.02 g Cobalt chloride 0.5 g Zinc chloride 20.0 gFerrous sulfate-7H2O 65.0gBiotin 0.2gSulfuric Acid 5.0 mlWater to a final volume of 1 literFilter sterilize and store at room temperature.Note: There may be a cloudy precipitate upon mixing of these ingredients. Filter-sterilize as above and use.11。

毕赤酵母手册

pPICZ A, B, and C
Pichia expression vectors for selection on Zeocin™ and purification of secreted, recombinant proteins
Cat. no. V195-20 Rev. Date: 7 July 2010 Manual part no. 25-0150
MAN0000035
User Manual
ii
Table of Contents
Important Information................................................................................................................................ v Accessory Products ................................................................................................................................... vii Introduction ................................................................................................................................................. 1 Overview .......................................................................................................................................................1 Methods........................................................................................................................................................ 2 Cloning into pPICZ A, B, and C...............................................................................................................2 Multiple Cloning Site of pPICZ A ...........................................................................................................5 Multiple Cloning Site of pPICZ B ............................................................................................................6 Multiple Cloning Site of pPICZ C............................................................................................................7 Pichia Transformation ..................................................................................................................................9 Expression in Pichia ....................................................................................................................................13 Purification ...........................................................................................................................15 Appendix .................................................................................................................................................... 17 Recipes .........................................................................................................................................................17 Zeocin™ ........................................................................................................................................................19 pPICZ Vector ............................................................................................................................................21 Lithium Chloride Transformation Method.............................................................................................23 Construction of In Vitro Multimers..........................................................................................................25 Technical Support.......................................................................................................................................33 Purchaser Notification ...............................................................................................................................34 References....................................................................................................................................................35

巴斯德毕赤酵母(Pichia pastoris)表达系统综述

毕赤酵母启动子以及诱导物

启动子诱导表达 AOX1，AOX2(甲醇氧化酶) 以甲醇诱导表达 GAP （3 一磷酸甘油醛脱氢酶）葡萄糖组成型表达（甘油或甲醇诱导产量只有2/3，1/3） FLD1（甲醛脱氢酶）以甲基化胺为氮源 (葡萄糖为碳源)，甲醇为碳源 (硫酸铵为氮源)表达 PEX8（过氧化物酶体基质蛋白）以葡萄糖、甲醇诱导表达 YPT1（GTP酶）以葡萄糖甲醇、甘露糖醇组成型表达
外源蛋白在巴斯德毕赤酵母中的表达种类

具有代表性的如下列一些外源蛋白质P.pastoris中已经获得高效产生： (1)蛋白酶类，如人溶菌酶、人胃促胰酶、葡萄糖苷酶等；（2）激素类，如胰岛素前体、人绒毛膜促性腺激素、鲤鱼生长激素等；（3）受体、抗体及单链抗体等生物活性蛋白； (4)抗原类，如乙型肝炎表面抗原、破伤风毒素片段C、登革热病毒E蛋白等； (5)细胞因子类，如肿瘤坏死因子、表皮生长因子、血管生成抑制因子等；（6）酶制剂类，如植酸酶等； (7)病毒蛋白类，如乙型脑炎病毒E蛋白、伪狂犬病病毒Ea株gE蛋白等

毕赤酵母的优点
利用受甲醇诱导的醇氧化酶(AOX1)启动子，可严格控制外源基因的表达
营养要求简单，生长快速，适合高密度大规模培养，很少产生有毒物质，毒性比细菌小，用甲醇不易染菌，可以减少污染。外源蛋白基因遗传高稳定性，外源蛋白质具有一定程度上的折叠加工和糖基化修饰，性质较原核表达的蛋白质更加稳定，特别适合于表达真核生物基因和制备有功能的蛋白质。
毕赤酵母发酵工艺对产量的影响

甲醇营养型毕赤酵母表达外源蛋白发酵一般有二个阶段，即酵母细胞营养生长阶段和外源蛋白表达阶段。酵母细胞生长阶段主要目的为达到一定的菌体量，另一方面通过流加限制甘油来抑制甲醇代谢途径，并使细胞从甘油相顺利向甲醇相过渡。蛋白表达阶段由于毕赤酵母具有以甲酵作为唯一碳源和能源的特性，且外源基因就插入在能够利用甲醇的 AOX基因中，当甘油用完时立刻补入甲醇诱导AOX基因产生醇氧化酶来利用甲醇，同时启动表达外源基因的AOX的启动子(PAOX)表达外源基因蛋白